S. Osanto

1.1k total citations
22 papers, 786 citations indexed

About

S. Osanto is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Internal Medicine. According to data from OpenAlex, S. Osanto has authored 22 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Internal Medicine. Recurrent topics in S. Osanto's work include Renal cell carcinoma treatment (6 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Central Venous Catheters and Hemodialysis (5 papers). S. Osanto is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Venous Thromboembolism Diagnosis and Management (6 papers) and Central Venous Catheters and Hemodialysis (5 papers). S. Osanto collaborates with scholars based in Netherlands, United States and United Kingdom. S. Osanto's co-authors include Frits R. Rosendaal, Jeanet W. Blom, Margot Tesselaar, Carine J.M. Doggen, Cornelis J. van Rooden, Menno V. Huisman, Jannemieke Ouwerkerk, M A Nooy, Roel Willemze and Judith E. Raber‐Durlacher and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

S. Osanto

21 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Osanto Netherlands	12	314	249	217	216	162	22	786
Lee Re United States	13	102 0.3×	211 0.8×	134 0.6×	154 0.7×	146 0.9×	23	739
R. Junker Germany	15	192 0.6×	109 0.4×	54 0.2×	186 0.9×	98 0.6×	29	828
Jonathan T. Wilde United Kingdom	15	140 0.4×	130 0.5×	84 0.4×	102 0.5×	31 0.2×	23	993
M. Stas Belgium	14	100 0.3×	346 1.4×	268 1.2×	144 0.7×	166 1.0×	26	665
Nilsson Im Sweden	19	259 0.8×	200 0.8×	51 0.2×	235 1.1×	57 0.4×	57	1.2k
Fernanda Andrade Orsi Brazil	19	233 0.7×	112 0.4×	15 0.1×	150 0.7×	72 0.4×	104	849
Janine Campbell Australia	14	126 0.4×	56 0.2×	48 0.2×	95 0.4×	71 0.4×	23	652
Levine Mn Canada	7	534 1.7×	64 0.3×	53 0.2×	370 1.7×	37 0.2×	8	838
Andrei Braester Israel	13	94 0.3×	102 0.4×	20 0.1×	58 0.3×	129 0.8×	63	625
Marie‐Lorraine Scrobohaci France	10	102 0.3×	77 0.3×	75 0.3×	74 0.3×	43 0.3×	17	674

Countries citing papers authored by S. Osanto

Since Specialization

Citations

This map shows the geographic impact of S. Osanto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Osanto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Osanto more than expected).

Fields of papers citing papers by S. Osanto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Osanto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Osanto. The network helps show where S. Osanto may publish in the future.

Co-authorship network of co-authors of S. Osanto

This figure shows the co-authorship network connecting the top 25 collaborators of S. Osanto. A scholar is included among the top collaborators of S. Osanto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Osanto. S. Osanto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oosterhuis, J. Wolter, Vincent T.H.B.M. Smit, Hans Stoop, et al.. (2013). Patient with two secondary somatic-type malignancies in a late recurrence of a testicular non-seminoma: illustration of potential and flaw of the cancer stem cell therapy concept. The International Journal of Developmental Biology. 57(2-3-4). 153–157. 10 indexed citations

Poppel, Hendrik Van, Nick Watkin, S. Osanto, et al.. (2013). Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 24. vi115–vi124. 70 indexed citations

Porta, Camillo, Bernard Escudier, Thomas E. Hutson, et al.. (2012). Relationship between Karnofsky Performance Status (KPS) and tumor response: analysis of the RECORD-1 phase 3 trial of everolimus in patients with advanced renal cell carcinoma (RCC). Data Archiving and Networked Services (DANS). 109. 9–10. 3 indexed citations

Porta, Camillo, Bernard Escudier, Thomas E. Hutson, et al.. (2011). Analysis of the relationship between Karnofsky performance status (KPS) and tumor response in the RECORD-1 phase III trial of everolimus in patients with advanced renal cell carcinoma (RCC).. Journal of Clinical Oncology. 29(15_suppl). 4610–4610. 1 indexed citations

Qin, Yongjun, Els M.E. Verdegaal, Marco Siderius, et al.. (2010). Quantitative expression profiling of G‐protein‐coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target. Pigment Cell & Melanoma Research. 24(1). 207–218. 100 indexed citations

Osanto, S., Thomas E. Hutson, B. Escudier, et al.. (2010). Efficacy and safety of everolimus in elderly patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 28(15_suppl). 4608–4608. 6 indexed citations

Leebeek, Frank W.G., et al.. (2008). Microparticle-Associated Tissue Factor Activity and Venous Thrombosis in Multiple Myeloma.. Blood. 112(11). 1812–1812. 1 indexed citations

Mulder, P.H.M. de, J.B.A.G. Haanen, Stefan Sleijfer, et al.. (2008). [Angiogenesis inhibitors for the systemic treatment of metastatic renal cell carcinoma: sunitinib, sorafenib, bevacizumab and temsirolimus].. PubMed. 152(7). 371–5. 1 indexed citations

Rooden, Cornelis J. van, Margot Tesselaar, S. Osanto, Frits R. Rosendaal, & Menno V. Huisman. (2005). Deep vein thrombosis associated with central venous catheters – a review. Journal of Thrombosis and Haemostasis. 3(11). 2409–2419. 114 indexed citations

10.

Blom, Jeanet W., Carine J.M. Doggen, S. Osanto, & Frits R. Rosendaal. (2005). Old and new risk factors for upper extremity deep venous thrombosis. Journal of Thrombosis and Haemostasis. 3(11). 2471–2478. 103 indexed citations

11.

Blom, Jeanet W., S. Osanto, & Frits R. Rosendaal. (2005). High risk of venous thrombosis in patients with pancreatic cancer: A cohort study of 202 patients. European Journal of Cancer. 42(3). 410–414. 79 indexed citations

12.

Tesselaar, Margot, Jannemieke Ouwerkerk, M A Nooy, Frits R. Rosendaal, & S. Osanto. (2004). Risk factors for catheter-related thrombosis in cancer patients. European Journal of Cancer. 40(15). 2253–2259. 96 indexed citations

13.

Tesselaar, Margot, Neeltje Steeghs, F.R. Rosendaal, & S. Osanto. (2004). Incidence of thrombosis in gastro-esophageal cancer; a cohort study of 761 patients. Journal of Clinical Oncology. 22(14_suppl). 8218–8218. 2 indexed citations

14.

Tesselaar, Margot, Jannemieke Ouwerkerk, Frits R. Rosendaal, & S. Osanto. (2001). Prophylaxis with low molecular weight heparin reduces the risk for catheter-related venous thrombosis in cancer patients with centrally but not peripherally inserted central venous catheters for administration of chemotherapy. European Journal of Cancer. 37. S354–S355. 9 indexed citations

15.

Raber‐Durlacher, Judith E., et al.. (2000). Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Supportive Care in Cancer. 8(5). 366–371. 92 indexed citations

16.

Schoemaker, Rik C., et al.. (1999). Pharmacokinetics of interleukin-2 in two anephric patients with metastatic renal cell cancer. Annals of Oncology. 10(11). 1381–1383. 11 indexed citations

17.

Elsas, Andrea van, et al.. (1997). Transfection of IL-2 Augments CTL Response to Human Melanoma Cells In Vitro. Journal of Immunotherapy. 20(5). 343–353. 13 indexed citations

18.

Osanto, S., et al.. (1997). Eradication of melanoma pulmonary metastases by immunotherapy with tumor cells engineered to secrete interleukin-2 or gamma interferon.. PubMed. 4(1). 33–41. 22 indexed citations

19.

Osanto, S., et al.. (1994). Transduction of human melanoma cells with the gamma interferon gene enhances cellular immunity.. PubMed. 1(3). 171–9. 19 indexed citations

20.

Osanto, S., et al.. (1983). Primary Plasma Cell Leukaemia. Acta Haematologica. 70(2). 122–129. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact